Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

17β-estradiol can reduce inflammation in the skin.

IL-10 may worsen alopecia areata instead of helping it.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

Inflammation is linked to hair loss.

Type 2 inflammation helps wound healing by switching immune cells to repair mode.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Exosomes from certain stem cells can fight hair loss by promoting hair growth and maintaining the growth phase of hair.

Effective acne treatments should reduce sebum, bacteria, and inflammation, with isotretinoin being the best for severe cases.

Annurca apple extract improved hair growth in mice and could potentially prevent hair loss.

The herbal mixture could potentially improve hair loss.

Adenosine can help treat hair loss by promoting hair growth.

EH-MSCs may help treat hair loss by reducing inflammation.

IL-17-producing γδ T cells help improve bone healing.

Equisetum debile extract, especially the ethyl acetate type, may be a promising natural ingredient for anti-hair loss products.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

IL-36α helps grow new hair follicles and speeds up wound healing.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

White fat tissue in the skin helps control inflammation by affecting certain immune cells.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.